Drug intelligence / Profile preview

deltamethrin + piperonyl butoxide

Development stage
Unknown
Lead developer
Ipogras Chile
Modality
Small Molecules
Administration
Topical
01

Overview

"deltamethrin + piperonyl butoxide" is a combination formulation that pairs the synthetic Type II pyrethroid insecticide deltamethrin with the synergist piperonyl butoxide (PBO). Deltamethrin exerts its insecticidal effect by binding to voltage-gated sodium channels in the insect nervous system, preventing their closure and causing prolonged sodium influx, which leads to continuous nerve firing, paralysis, and death. PBO acts as a synergist by inhibiting cytochrome P450 monooxygenases (mixed-function oxidases) in insects, which are the primary enzymes responsible for the metabolic detoxification of pyrethroids. By blocking these enzymes, PBO prevents the breakdown of deltamethrin, thereby restoring its potency against pyrethroid-resistant insect populations. This combination is widely utilized in public health vector control, particularly on long-lasting insecticidal nets (LLINs) such as PermaNet 3.0 and DawaPlus 3.0/4.0 to combat malaria-transmitting mosquitoes. Additionally, it is formulated as a topical pediculicide and scabicide (e.g., Launol) for the treatment of head lice and scabies in humans.

Brand names
DawaPlus 3.0DawaPlus3.0DawaPlus-3.0DawaPlus 4.0DawaPlus4.0DawaPlus-4.0LaunolPermaNet 3.0PermaNet3.0PermaNet-3.0
Other names
deltamethrin + PBOdeltamethrin and piperonyl butoxidedeltamethrin-PBOdeltamethrin-piperonyl butoxide
02

Targets

Cyp (Cyclophilin family)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on deltamethrin + piperonyl butoxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on deltamethrin + piperonyl butoxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call